2022 KEYNOTE INFORMATION

PLENARY LOCATION: Vivaldi 1 & 2

PLENARY KEYNOTES: THE FUTUREOF FIT-FOR-PURPOSE, SUSTAINABLE BIOPROCESSING

Alois Jungbauer, PhD, Professor & Head, Biotechnology, Institute of Bioprocess Science and Engineering, University of Natural Resources and Life Sciences (BOKU)
Professor Alois Jungbauer received his PhD in Food Technology and Biotechnology from the University of Natural Resources and Life Sciences Vienna, Austria 1986. He serves since then as a professor at the Department of Biotechnology. He teaches Protein Technology and Downstream Processing and Bioprocess Engineering. He also acts as area head and Deputy Director of Research in the Austrian Centre of Industrial Biotechnology. He is currently working in the field of bioengineering of proteins, plasmids and viruses with special focus on expression, downstream processing and characterization of large biomolecules.  For more than 10 years he is working on continuous manufacturing of biopharmaceuticals. As a proliferate researcher he has more than 340 publications on recombinant protein production and bioseparation, 17 patents and 12 book contributions and recently a monograph entitled “Protein Chromatography , Process Development and Scale Up”. He is executive editor and co-founder of Biotechnology Journal, and member of editorial boards from numerous journals in the area of biochemical engineering.  He acts also a the vice president of research of the European Society of Biochemical Engineering Science.

Stefan R. Schmidt, MBA, PhD, COO & Head, Operations, BioAtrium AG
Dr. Stefan R. Schmidt MBA, currently serves as Head of Operations/COO at BioAtrium AG, a joint venture of Lonza and Sanofi in Visp, Switzerland. Previously he held the position as CSO and other senior executive roles at Rentschler Biopharma with overall responsibilities for development and production for more than 5 years. Before that, he was CSO at ERA Biotech in Barcelona, directing the company’s R&D efforts. Prior to that, he worked for 7 years at AstraZeneca in Sweden where he led the unit of Protein Sciences as Associate Director. He started his leadership career at Biotech companies in Munich where he built up protein biochemistry teams for Connex and GPC-Biotech.

Track Keynotes

Stream 1: Upstream

Zorica Dragic, PhD, Director, Cell LIne Screening and Development, Novartis Pharma AG, Switzerland

Christoph Herwig, PhD, Head Research Area Biochemical Engineering, TU Vienna, Austria

Stream 2: Downstream

Sophia Hober, PhD, Professor, School of Biotechnology, KTH Royal Institute of Technology

Massimo Morbidelli, PhD, Professor, Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano

Stream 3: Gene and Cell Therapy

Matthias Renner, PhD, Scientific Assessor, Federal Institute for Vaccines & Biomedicines, Paul-Ehrlich-Institut

Florence Salmon, PhD, Head, Regulatory Affairs, Tigen Pharma

Stream 4: Analytics and Formulation

Thomas M. Spitznagel, PhD, Senior Vice President, Biopharmaceutical Development & Manufacturing, MacroGenics, Inc., United States

Paolo Arosio, PhD, Assistant Professor, Chemistry & Applied Biosciences, ETH Zurich, Switzerland.